rs1049434

This is a variant in the SLC16A1 gene that changes a aspartate to an glutamate.

ClinVar annotation

Benign★★★
10 submitters3 publications

Exercise-induced hyperinsulinism (HHF7); Ketoacidosis due to monocarboxylate transporter-1 deficiency; Metabolic myopathy due to lactate transporter defect; not specified

View on ClinVar →

Research that mentions this SNP (1)

Polymorphisms of monocarboxylate transporter genes are associated with clinical outcomes in patients with colorectal cancer
AssociationN=697Fei Fei et al.(2015)· Journal of Cancer Research and Clinical Oncology

This study examined associations between nine SNPs in monocarboxylate transporter genes (MCT1, MCT2, MCT4) and clinical outcomes in 697 Chinese colorectal cancer patients. MCT1 rs1049434 was significantly associated with overall survival (HR 0.74, P=0.046), while MCT2 rs995343 was associated with recurrence-free survival (HR 0.74, P=0.036). A cumulative effect analysis showed that patients with three unfavorable genotypes had a 2.06-fold increased recurrence risk compared to those with no unfavorable genotypes.

Traits studied:Colorectal cancerOverall survivalRecurrence-free survival

About SLC16A1

The protein encoded by this gene is a proton-linked monocarboxylate transporter that catalyzes the movement of many monocarboxylates, such as lactate and pyruvate, across the plasma membrane. Mutations in this gene are associated with erythrocyte lactate transporter defect. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Oct 2009]

View all SLC16A1 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…